Authors & Contributors
Authors
Patrick LaFontaine
Associate Director, Global HEOR, Oncology, Sanofi, NJ, USA
Alin Kalayjian, PharmD, MBA
US Medical Evidence Generation Post-doctoral Fellow,
GSK and Rutgers University, NJ, USA
Aarth Sheth, PharmD, RPh
HEOR Fellow, Novo Nordisk and Rutgers University, NJ, USA
Daryl S. Spinner, PhD, MBA, BS, VP
Market Access & Reimbursement, Variantyx, Inc., NC, USA
Contributors
Kelly Lenahan, MPH,
Director, Global HTA Initiatives, Scientific
and Health Policy Initiatives, ISPOR
John Guerino, MHS
Manager, Scientific and Health Policy Initiatives, ISPOR
Theresa Tesoro, MSN
Associate Director, Scientific
and Health Policy Initiatives, ISPOR
Acknowledgements
Professor Finn Boerlum Kristensen, PhD, MD
Danish Centre for Health Economics,
University of Southern Denmark, Denmark
Laura Pizzi, PharmD, MPH
Chief Science Officer, ISPOR
Mitch Higashi, PhD, MBA
Associate Chief Science Officer, ISPOR
Karen Worley, MS, PhD, Director
Humana Healthcare, OH, USA
Bruce Gingles
Cook Medical, IN, USA
James F Murray, PhD
Research Fellow, Eli Lilly and Company, IN, USA
Carla Zema, PhD
Zema Consulting, AL, USA